Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008 Feb;65(2):279-80.
doi: 10.1111/j.1365-2125.2007.03020.x. Epub 2007 Sep 13.

Serious haematological toxicity of cyclophosphamide in relation to CYP2B6, GSTA1 and GSTP1 polymorphisms

Agnès Tran, François Bournerias, Christine Le Beller, Olivier Mir, Elisabeth Rey, Gérard Pons, Michel Delahousse, Jean-Marc Tréluyer
Case Reports

Serious haematological toxicity of cyclophosphamide in relation to CYP2B6, GSTA1 and GSTP1 polymorphisms

Agnès Tran et al. Br J Clin Pharmacol. 2008 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cyclophosphamide metabolic pathways (adapted from Timm et al.[2]). The mutations (1) CYP2B6516TT, (2) CYP2C9*1/*3, (3) CYP3A5*3/*3, (4) GSTA1*A/*B, and (5) GSTP1*A/*B were identified in the presented case
See this image and copyright information in PMC

References

    1. de Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet. 2005;44:1135–64. - PubMed
    1. Timm R, Kaiser R, Lotsch J, Heider U, Sezer O, Weisz K, Montemurro M, Roots I, Cascorbi I. Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19. Pharmacogenomics J. 2005;5:365–73. - PubMed
    1. Xie H, Griskevicius L, Stahle L, Hassan Z, Yasar U, Rane A, Broberg U, Kimby E, Hassan M. Related pharmacogenetics of cyclophosphamide in patients with hematological malignancies. Eur J Pharm Sci. 2006;27:54–61. - PubMed
    1. Sweeney C, Ambrosone CB, Joseph L, Stone A, Hutchins LF, Kadlubar FF, Coles BF. Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment. Int J Cancer. 2003;103:810–4. - PubMed
    1. Ishimoto TM, Ali-Osman F. Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics. 2002;12:543–53. - PubMed

MeSH terms